Imatinib is a relatively selective small molecule inhibitor of a limited number of tyrosine kinases—including KIT, PDGFRA, and the intracellular ABL kinase—that has helped to transform the management of GIST. The gene discussed is PDGFRA; the disease is gastrointestinal stromal tumor.